Align TechnologyXTER:AFW 89 FCF Margin % is 11.56% as of Mar. 2026, which is 30% below its 10-year median of 16.44. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €212.06 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Align Technology ranks better than 83.19% on this metric.
The historical rank and industry rank for Align Technology's FCF Margin % or its related term are showing as below:
XTER:AFW'
s FCF Margin % Range Over the Past 10 Years
Min: 7.41 Med: 16.44 Max: 24.83
Current: 14.23
During the past 13 years, the highest FCF Margin % of Align Technology was 24.83%. The lowest was 7.41%. And the median was 16.44%.
XTER:AFW's FCF Margin % is ranked better than 83.19% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs XTER:AFW: 14.23
Align Technology FCF Margin % Related Terms
Align Technology FCF Margin % Historical Data
* Premium members only.
The historical data trend for Align Technology's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AFW vs SOLV, COO, BAX: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Align Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Align Technology's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology (XTER:AFW) has a FCF Margin % of 11.56% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Align Technology and its competitors. This is 30% below median its historical median of 16.44. Over the past decade, Align Technology's FCF Margin % has ranged from 7.41 to 24.83. According to the industry distribution chart, Align Technology ranks #137 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 16.8%.
Is Align Technology's FCF Margin % too high?
Align Technology's current FCF Margin % of 11.56% is 30% below median its 10-year median of 16.44. Over the past 10 years, this metric has ranged from a low of 7.41 to a high of 24.83. Based on the distribution chart, Align Technology ranks #137 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Align Technology has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's FCF Margin % compare to SOLV and COO?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #137 out of 815 companies for FCF Margin %. This places Align Technology in the top 17% of its industry — outperforming the majority of peers. Historically, Align Technology's own FCF Margin % has ranged from 7.41 to 24.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Align Technology and its competitors. Align Technology's current FCF Margin % is 11.56%, which is 30% below median its own 10-year median of 16.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Significantly Undervalued. The stock's GF Value™ is €212.06, compared to a current price of €149.05 — trading 29.7% below its estimated fair value. The current FCF Margin % is 11.56%, which is 30% below median its 10-year median of 16.44. Align Technology's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current FCF Margin % is 11.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (XTER:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €149.05 is trading 29.7% below its estimated GF Value™ of €212.06.
GuruFocus considers Align Technology to be Significantly Undervalued.
Key valuation signals for XTER:AFW:
FCF Margin %: 11.56% (30% below median its 10-year median of 16.44)
GF Value™: €212.06 vs. price of €149.05 (29.7% below fair value)
No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score
Get the complete analysis for XTER:AFW
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AFW has been successfully added to your 
